Ειδήσεις: DENALI THERAPEUTICS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

30/03 08:28 defenseworld.net

Equities Analysts Offer Predictions for DNLI FY2027 Earnings

Denali Therapeutics HC Wainwright FY2027 EPS Buy rating $42 price target equity research

27/03 11:28 defenseworld.net

Denali Therapeutics (NASDAQ:DNLI) Price Target Raised to $40.00 at The Goldman Sachs Group

Denali Therapeutics Goldman Sachs price target buy rating analyst ratings

27/03 10:54 defenseworld.net

Stifel Nicolaus Issues Positive Forecast for Denali Therapeutics (NASDAQ:DNLI) Stock Price

Denali Therapeutics DNLI Stifel Nicolaus price target buy rating UBS

26/03 19:28 statnews.com

STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more

FDA Denali Therapeutics Hunter syndrome rare disease drug PTO chief pharma regulation

26/03 19:28 statnews.com

STAT+: Denali Therapeutics, Corcept Therapeutics win FDA approvals

FDA approvals Denali Therapeutics Corcept Therapeutics Sarepta Allogene CAR‑T

25/03 18:21 statnews.com

STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome

FDA approval Denali Therapeutics Hunter syndrome rare disease drug lysosomal storage disorder drug approval

17/03 07:32 defenseworld.net

Denali Therapeutics Teases April 5 FDA Decision for Tivi as Launch Plans and Pipeline Catalysts Build

Denali Therapeutics Tivi FDA decision Hunter syndrome pipeline neurodegenerative diseases

17/03 07:32 defenseworld.net

Denali Therapeutics Teases April 5 FDA Decision for Tivi as Launch Plans and Pipeline Catalysts Build

Denali Therapeutics Tivi FDA decision Hunter syndrome pipeline neurodegenerative diseases

Loading...